SYNETS
"SYNETS" is a word mark owned by Biogency Pty Ltd, filed at the USPTO on February 3, 2023. It is registered and covers class 5 (Pharmaceuticals).
- Status
- Registered
- Since July 30, 2024
- Filed
- February 3, 2023
- Registered
- July 30, 2024
- Priority date
- January 24, 2023
- Claimed from Australia
- Application no.
- 97779299
- Registration no.
- 7459948
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns SYNETS
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Biogency Pty Ltd
Alexandria, Australia
Representative
Jennifer A. Visintine
Thompson Coburn LLP
What the mark covers
The products and services SYNETS is filed for, grouped by Nice class.
Food supplements, namely, anti-oxidants; Capsules sold empty for pharmaceutical purposes; Capsules sold empty for veterinary pharmaceutical preparations; Chemical preparations for pharmaceutical use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Collagen based medicated supplements; Decoctions for pharmaceutical purposes to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Antioxidants in the nature of dietary supplements; Dietary protein supplements; Dietary supplements; Dietary supplements for animals; Dietary supplements with a cosmetic effect; Effervescent pharmaceutical preparations to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Food supplements for medical purposes; Herbal dietary supplements; Dietary nutritional supplements; Nutritional supplements; Medicinal plant compounds for use as dietary supplements; Plant compounds for use as veterinary dietary supplements ; Plant extracts being dietary supplements; Medicated lozenges for pharmaceutical purposes; skin lotions for pharmaceutical purposes; Pharmaceutical drugs to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical preparations containing vitamins to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical preparations for health care to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical preparations for human use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical preparations for oral use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical preparations for skin care; Pharmaceutical preparations for veterinary use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Chemical products for pharmaceutical use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Natural pharmaceutical products to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Pharmaceutical products to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Tablets being pharmaceuticals to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; Food supplements for animals in the nature of vitamins; Vitamin supplements; Dietary food supplements; Nutritional drinks being dietary food supplements; Food supplements in the nature of dietary supplements
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of registration confirmation emailed
- Registered-principal register
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Teas/email correspondence entered
- Correspondence received in law office
- Assigned to lie
- Teas response to suspension inquiry received
10 earlier steps on the official record.
About SYNETS
Who owns the trademark "SYNETS"?
The USPTO trademark "SYNETS" (application 97779299) is owned by Biogency Pty Ltd.
What is the status of "SYNETS"?
Its status at the USPTO is: registered.
When was "SYNETS" registered?
It was registered on July 30, 2024.
Get this data via the API
Everything on this page comes from the Signa API. Pull SYNETS and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2b57-e3ff-712c-b6c5-8d050c249c6a
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2b57-e3ff-712c-b6c5-8d050c249c6a",
"object": "trademark",
"mark_text": "SYNETS",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "97779299",
"filing_date": "2023-02-03",
"nice_classes": [
5
],
"owners": [
{
"name": "Biogency Pty Ltd",
"entity_id": "ent_019eb7e7-eacb-75fe-a1ac-e8e88de68299"
}
]
}